Author
Listed:
- Yang Luo
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
- Sara Suliman
(Brigham and Women’s Hospital, Harvard Medical School)
- Samira Asgari
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
- Tiffany Amariuta
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
- Yuriy Baglaenko
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
- Marta Martínez-Bonet
(Brigham and Women’s Hospital, Harvard Medical School)
- Kazuyoshi Ishigaki
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
- Maria Gutierrez-Arcelus
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
- Roger Calderon
(Socios En Salud)
- Leonid Lecca
(Socios En Salud)
- Segundo R. León
(Socios En Salud)
- Judith Jimenez
(Socios En Salud)
- Rosa Yataco
(Socios En Salud)
- Carmen Contreras
(Socios En Salud)
- Jerome T. Galea
(University of South Florida)
- Mercedes Becerra
(Harvard Medical School)
- Sergey Nejentsev
(University of Cambridge
Amsterdam University Medical Centers)
- Peter A. Nigrovic
(Brigham and Women’s Hospital, Harvard Medical School
Boston Children’s Hospital)
- D. Branch Moody
(Brigham and Women’s Hospital, Harvard Medical School)
- Megan B. Murray
(Harvard Medical School)
- Soumya Raychaudhuri
(Brigham and Women’s Hospital, Harvard Medical School
Harvard Medical School
Broad Institute of MIT and Harvard
Harvard Medical School)
Abstract
Of the 1.8 billion people worldwide infected with Mycobacterium tuberculosis, 5–15% will develop active tuberculosis (TB). Approximately half will progress to active TB within the first 18 months after infection, presumably because they fail to mount an effective initial immune response. Here, in a genome-wide genetic study of early TB progression, we genotype 4002 active TB cases and their household contacts in Peru. We quantify genetic heritability ( $${\it{h}}_{\it{g}}^2$$ h g 2 ) of early TB progression to be 21.2% (standard error 0.08). This suggests TB progression has a strong genetic basis, and is comparable to traits with well-established genetic bases. We identify a novel association between early TB progression and variants located in a putative enhancer region on chromosome 3q23 (rs73226617, OR = 1.18; P = 3.93 × 10−8). With in silico and in vitro analyses we identify rs73226617 or rs148722713 as the likely functional variant and ATP1B3 as a potential causal target gene with monocyte specific function.
Suggested Citation
Yang Luo & Sara Suliman & Samira Asgari & Tiffany Amariuta & Yuriy Baglaenko & Marta Martínez-Bonet & Kazuyoshi Ishigaki & Maria Gutierrez-Arcelus & Roger Calderon & Leonid Lecca & Segundo R. León & J, 2019.
"Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians,"
Nature Communications, Nature, vol. 10(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11664-1
DOI: 10.1038/s41467-019-11664-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11664-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.